4.7 Article

Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes

Journal

NATURE IMMUNOLOGY
Volume 10, Issue 9, Pages 1026-U107

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1773

Keywords

-

Categories

Funding

  1. US National Institutes of Health [U01 DK078123-03, U19-DK 61934, U19-AI050864]
  2. Canadian Institutes of Health Research
  3. American Diabetes Association
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, R01AI083628] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061934, U01DK078123] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Type 1 diabetes may result from a breakdown in peripheral tolerance that is partially controlled by the expression of peripheral tissue antigens (PTAs) in lymph nodes. Here we show that the transcriptional regulator Deaf1 controls the expression of genes encoding PTAs in the pancreatic lymph nodes (PLNs). The expression of canonical Deaf1 was lower, whereas that of an alternatively spliced variant was higher, during the onset of destructive insulitis in the PLNs of nonobese diabetic (NOD) mice. We identified an equivalent variant Deaf1 isoform in the PLNs of patients with type 1 diabetes. Both the NOD mouse and human Deaf1 variant isoforms suppressed PTA expression by inhibiting the transcriptional activity of canonical Deaf1. Lower PTA expression resulting from the alternative splicing of DEAF1 may contribute to the pathogenesis of type 1 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available